Avior Wealth Management, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1599868 OMAHA, NE

Position in PCVX

as of Mar 31, 2026 · filed Apr 9, 2026 Compact

Position Value

$502,477

+$64,747 QoQ

Shares Held

8,647

-8.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Avior Wealth Management, LLC holds $6,163,519 across 10 Biotechnology names. PCVX ranks #5 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,054	$1,363,733
2	ASND	Ascendis Pharma A/S	5,463	$1,249,551
3	REGN	Regeneron Pharmaceuticals, Inc.	1,399	$1,080,923
4	INSM	INSMED Inc	3,994	$653,098
5	PCVX	Vaxcyte, Inc. This page	8,647	$502,477
6	RYTM	Rhythm Pharmaceuticals, Inc.	4,650	$404,410
7	ABVX	Abivax S.A.	3,240	$360,774
8	RVMD	Revolution Medicines, Inc.	3,327	$323,550

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$502,477	8,647	-8.9%	Shares	Sole	2026-04-09
2025-12-31	$437,730	9,487	-14.0%	Shares	Sole	2026-01-06
2025-09-30	$397,336	11,031	+29.3%	Shares	Sole	2025-11-14
2025-06-30	$277,277	8,529	+25.4%	Shares	Sole	2025-07-17
2025-03-31	$256,730	6,799	+5.3%	Shares	Sole	2025-04-21
2024-12-31	$528,488	6,456	+21.1%	Shares	Sole	2025-01-17
2024-09-30	$609,287	5,332	-8.6%	Shares	Sole	2024-11-08
2024-06-30	$440,298	5,831	+24.0%	Shares	Sole	2024-08-13
2024-03-31	$321,193	4,702	+0.7%	Shares	Sole	2024-04-30
2023-12-31	$293,276	4,670	+33.9%	Shares	Sole	2024-01-30
2023-09-30	$177,767	3,487	—	Shares	Sole	2023-10-17
No filing history on record for this holder in this stock.